Topterone (, ) (developmental code name WIN-17665), also known as 17α-propyltestosterone (or simply propyltestosterone) or as 17α-propylandrost-4-en-17β-ol-3-one, is a
steroidal antiandrogen that was first reported in 1978 and was developed for
topical administration
A topical medication is a medication that is applied to a particular place on or in the body. Most often topical medication means application to body surfaces such as the skin or mucous membranes to treat ailments via a large range of classes ...
but, due to poor effectiveness, was never marketed.
See also
*
Steroidal antiandrogen
*
List of steroidal antiandrogens
This is a list of steroidal antiandrogens.
Progesterone derivatives
* 11α-Hydroxyprogesterone = 11α-hydroxyprogesterone
* Chlormadinone acetate = 17α-acetoxy-6-chloro-δ6-progesterone
* Clometerone (L-38000) = 6α-chloro-16α-methylproge ...
References
Abandoned drugs
Androstanes
Anti-acne preparations
Steroidal antiandrogens
{{Dermatologic-drug-stub